Payer Sciences
Alejandro Jaramillo García is the VP of Market Access Analytics at Payer Sciences, where Alejandro leads projects related to payer segmentation, pricing, and formulary optimization for major pharmaceutical clients. Prior to this role, Alejandro held positions at Real Chemistry, PatientPoint®/OutcomeHealth, Novartis Oncology, Johnson & Johnson Consumer Health Care, Bayer, Johnson & Johnson, Bloomberg LP, Merck, and STADA with a focus on data analytics, ML, and AI in various healthcare sectors. Alejandro holds a Master of Science in Statistics from the New Jersey Institute of Technology and a Bachelor's degree in Physics from Rutgers, The State University of New Jersey.
Payer Sciences
Tasked with tackling a labyrinth of payers and organized customers, with limited resources, payer marketers can sometimes feel trapped between a rock and—well…you know. Which is why our clients need an agency that knows how to rock in a hard space. Since day one, Payer Sciences has approached managed markets from a different angle. We firmly believe the truth lies in the data. We relentlessly analyze what formulary decision-makers and prescribers actually do, revealing patterns and practices that impact stakeholders across the treatment journey, and drive bottom-line results. This disciplined approach requires an investment in sharp minds and multiple perspectives. To that end, Payer Sciences has assembled a flat and flexible organization, with analytics, consulting and communications living together under one roof—as one fully aligned team—so that we’re always ready to rock. No matter how hard the space. Payer Sciences is part of Publicis Health North America, and a subsidiary of the Publicis Group (OTCQX: PUBGY).